Jiangsu Pacific minok bio Pharmaceutical Co., Ltd
EN CN
 
  • SCIENCE & RESEARCH
  • Safety and efficacy of meplazumab in healthy volunteers and COVID-19 patients: a randomized phase 1 and an exploratory phase 2 trial
    		 
    CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
    		 
    Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
     
    Basolateral CD147 Induces Hepatocyte Polarity Loss
    by E-cadherin Ubiquitination and Degradation in Hepatocellular Carcinoma Progress
    		 
    Disrupting CD147-RAP2 interaction abrogates erythrocyte invasion
    by Plasmodium falciparum
    		 
    Randomized Trial of [] Metuximab in Treatment of Hepatocellular Carcinoma After Percutaneous Radiofrequency Ablation
    •  
  • COMPANY
  • About us
  • Vision
  • Mission
  • History
  • Team
  • News and events
  • News and events
  • Meet us
  • SCIENCE & RESEARCH
  • New target
  • Oncology
  • Infectious diseases
  • Research collaborations
  • Clinical trial capabilities
  • Our pipeline
  • Science & research
  • Expanded Access
  • CAREER
  • Working with us
  • Job vacancies
  • TECHNOLOGIES
  • Process science
  • Expression system
  • Process development
  • GMP manufacturing
  • Quality Control
  • Quality Management
  • CDMO
  • Business opportunities
  • CONTACT US
  • Location
  • Contact
    		•
    Stay up to date on Pacific Meinuoke
    © Pacific Meinuoke         Legal Notice       苏ICP备10218680号-1